Alithea Genomics
Switzerland · Biotech · AI
Alithea Genomics supplies RNA-sequencing preparation kits and services for laboratories running large gene-expression and drug-screening studies.
Preparing many samples for RNA sequencing
The company’s BRB-seq technology prepares multiplexed bulk RNA libraries for large cohorts and multi-condition experiments. DRUG-seq supports extraction-free workflows for cell-based screening, helping researchers study how compounds affect gene expression.
Alithea sells kits and offers sequencing-preparation services for uses such as mechanism-of-action studies and toxicology profiling. Its product range covers purified RNA, cell lines, organoids, spheroids and other sample types. The laboratory workflow is designed to increase the number of samples that researchers can process together.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | CHF 3M | Genku Ventures — LeadNovalis Biotech — ParticipantZürcher Kantonalbank — Participant |